News

Deal Announcements

Saladax Raises Series C Venture Capital Round

Tuesday, March 9, 2010 5:53:00 AM PDT | VentureDeal Staff
Bethlehem, Pennsylvania  --  Biotechnology company Saladax Biomedical has secured $8.4 million in its third round of institutional venture capital investment.

Saladax is developing what it calls "fast and inexpensive immunoassays that will enable routine blood level monitoring of anticancer drugs."

Investors in the round included Ben Franklin Technology Partners, Delaware Crossing Investor Group, Excel Venture Management and the Life Sciences Greenhouse of Central Pennsylvania.  The company said that the funding would be used to accelerate its product development and clinical support.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1